Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210051![]() (US10576087, Compound 2.29 | US9273046, 2.29 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.25 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210052![]() (US10576087, Compound 2.30 | US9273046, 2.30) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.25 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210020![]() (US10576087, Compound 2.26 | US9273046, 2.26 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.25 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210021![]() (US10576087, Compound 2.27 | US9273046, 2.27 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.25 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210037![]() (US10576087, Compound 2.1 | US9273046, 2.1 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210022![]() (US10576087, Compound 2.31 | US9273046, 2.31 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.350 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210015![]() (US10576087, Compound 2.21 | US9273046, 2.21 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372977![]() (US10576087, Compound 2.4a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.540 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210044![]() (US10576087, Compound 2.4 | US9273046, 2.4 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.560 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210024![]() (US10576087, Compound 2.33 | US9273046, 2.33 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210002![]() (US10576087, Compound 2.8 | US9273046, 2.8 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.710 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210052![]() (US10576087, Compound 2.30 | US9273046, 2.30) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.720 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210023![]() (US10576087, Compound 2.32 | US9273046, 2.32 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210016![]() (US10576087, Compound 2.22 | US9273046, 2.22 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372967![]() (US10576087, Compound 2.2a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210015![]() (US10576087, Compound 2.21 | US9273046, 2.21 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210034![]() (US10576087, Compound 1.1 | US9273046, 1.1 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210038![]() (US10576087, Compound 2.2 | US9273046, 2.2 | US9895...) | PDB GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210013![]() (US10576087, Compound 2.19 | US9273046, 2.19 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210007![]() (US10576087, Compound 2.13 | US9273046, 2.13 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210001![]() (US10576087, Compound 2.7 | US9273046, 2.7 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210044![]() (US10576087, Compound 2.4 | US9273046, 2.4 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210021![]() (US10576087, Compound 2.27 | US9273046, 2.27 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372985![]() (US10576087, Compound 2.5b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372978![]() (US10576087, Compound 2.4b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372974![]() (US10576087, Compound 2.3a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210037![]() (US10576087, Compound 2.1 | US9273046, 2.1 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210032![]() (US10576087, Compound 3.7 | US9273046, 3.7 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210051![]() (US10576087, Compound 2.29 | US9273046, 2.29 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210023![]() (US10576087, Compound 2.32 | US9273046, 2.32 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210005![]() (US10576087, Compound 2.11 | US9273046, 2.11 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372977![]() (US10576087, Compound 2.4a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210009![]() (US10576087, Compound 2.15 | US9273046, 2.15 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210022![]() (US10576087, Compound 2.31 | US9273046, 2.31 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210002![]() (US10576087, Compound 2.8 | US9273046, 2.8 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210010![]() (US10576087, Compound 2.16 | US9273046, 2.16 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210016![]() (US10576087, Compound 2.22 | US9273046, 2.22 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372973![]() (US10576087, Compound 2.3b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210006![]() (US10576087, Compound 2.12 | US9273046, 2.12 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.10 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210025![]() (US10576087, Compound 2.34 | US9273046, 2.34 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210018![]() (US10576087, Compound 2.24 | US9273046, 2.24 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210014![]() (US10576087, Compound 2.20 | US9273046, 2.20 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210000![]() (US10576087, Compound 2.6 | US9273046, 2.6 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210003![]() (US10576087, Compound 2.9 | US9273046, 2.9 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210041![]() (US10576087, Compound 2.3 | US9273046, 2.3 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210047![]() (US10576087, Compound 2.5 | US9273046, 2.5 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210011![]() (US10576087, Compound 2.17 | US9273046, 2.17 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210036![]() (US10576087, Compound 1.3 | US9273046, 1.3) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210011![]() (US10576087, Compound 2.17 | US9273046, 2.17 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210005![]() (US10576087, Compound 2.11 | US9273046, 2.11 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210024![]() (US10576087, Compound 2.33 | US9273046, 2.33 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210012![]() (US10576087, Compound 2.18 | US9273046, 2.18 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210028![]() (US10576087, Compound 3.1 | US9273046, 3.1) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372967![]() (US10576087, Compound 2.2a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210038![]() (US10576087, Compound 2.2 | US9273046, 2.2 | US9895...) | PDB GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210007![]() (US10576087, Compound 2.13 | US9273046, 2.13 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372968![]() (US10576087, Compound 2.2b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.80 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210008![]() (US10576087, Compound 2.14 | US9273046, 2.14 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.70 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210001![]() (US10576087, Compound 2.7 | US9273046, 2.7 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372974![]() (US10576087, Compound 2.3a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210034![]() (US10576087, Compound 1.1 | US9273046, 1.1 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210013![]() (US10576087, Compound 2.19 | US9273046, 2.19 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372985![]() (US10576087, Compound 2.5b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210057![]() (US10576087, Compound 2.35 | US9273046, 2.35 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210035![]() (US10576087, Compound 1.2 | US9273046, 1.2 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210006![]() (US10576087, Compound 2.12 | US9273046, 2.12 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210009![]() (US10576087, Compound 2.15 | US9273046, 2.15 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210010![]() (US10576087, Compound 2.16 | US9273046, 2.16 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210020![]() (US10576087, Compound 2.26 | US9273046, 2.26 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210047![]() (US10576087, Compound 2.5 | US9273046, 2.5 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210053![]() (US10576087, Compound 3.5 | US9273046, 3.5 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM372981![]() (US10576087, Compound 2.5a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372978![]() (US10576087, Compound 2.4b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210000![]() (US10576087, Compound 2.6 | US9273046, 2.6 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210027![]() (US10576087, Compound 2.37 | US9273046, 2.37 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210004![]() (US10576087, Compound 2.10 | US9273046, 2.10 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210032![]() (US10576087, Compound 3.7 | US9273046, 3.7 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210008![]() (US10576087, Compound 2.14 | US9273046, 2.14 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210025![]() (US10576087, Compound 2.34 | US9273046, 2.34 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372973![]() (US10576087, Compound 2.3b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210026![]() (US10576087, Compound 2.36 | US9273046, 2.36 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210041![]() (US10576087, Compound 2.3 | US9273046, 2.3 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210014![]() (US10576087, Compound 2.20 | US9273046, 2.20 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210017![]() (US10576087, Compound 2.23 | US9273046, 2.23 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210019![]() (US10576087, Compound 2.25 | US9273046, 2.25 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210003![]() (US10576087, Compound 2.9 | US9273046, 2.9 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210018![]() (US10576087, Compound 2.24 | US9273046, 2.24 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 47 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372968![]() (US10576087, Compound 2.2b | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210028![]() (US10576087, Compound 3.1 | US9273046, 3.1) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210053![]() (US10576087, Compound 3.5 | US9273046, 3.5 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210030![]() (US10576087, Compound 3.4 | US9273046, 3.4 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210057![]() (US10576087, Compound 2.35 | US9273046, 2.35 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 61 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210035![]() (US10576087, Compound 1.2 | US9273046, 1.2 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210004![]() (US10576087, Compound 2.10 | US9273046, 2.10 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210050![]() (US10576087, Compound 2.28 | US9273046, 2.28) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210054![]() (US10576087, Compound 3.6 | US9273046, 3.6 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 86 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210036![]() (US10576087, Compound 1.3 | US9273046, 1.3) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 88 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210012![]() (US10576087, Compound 2.18 | US9273046, 2.18 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 89 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210029![]() (US10576087, Compound 3.3 | US9273046, 3.3) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 104 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210026![]() (US10576087, Compound 2.36 | US9273046, 2.36 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 117 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM372981![]() (US10576087, Compound 2.5a | US9895376, Compound 2....) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 126 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210027![]() (US10576087, Compound 2.37 | US9273046, 2.37 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 173 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210017![]() (US10576087, Compound 2.23 | US9273046, 2.23 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 204 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210031![]() (US10576087, Compound 3.2 | US9273046, 3.2 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 223 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210050![]() (US10576087, Compound 2.28 | US9273046, 2.28) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 232 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210030![]() (US10576087, Compound 3.4 | US9273046, 3.4 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 291 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210033![]() (US10576087, Compound 3.8 | US9273046, 3.8 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 432 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210054![]() (US10576087, Compound 3.6 | US9273046, 3.6 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 518 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210029![]() (US10576087, Compound 3.3 | US9273046, 3.3) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 522 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210031![]() (US10576087, Compound 3.2 | US9273046, 3.2 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 569 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210019![]() (US10576087, Compound 2.25 | US9273046, 2.25 | US98...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 849 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210033![]() (US10576087, Compound 3.8 | US9273046, 3.8 | US9895...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210056![]() (US10576087, Compound Intermediate II | US9273046, ...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.92E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-Raf (Y340D/Y341D) (Homo sapiens (Human)) | BDBM210055![]() (US10576087, Compound Intermediate I | US9273046, I...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210055![]() (US10576087, Compound Intermediate I | US9273046, I...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
B-RAF V600E (Homo sapiens (Human)) | BDBM210056![]() (US10576087, Compound Intermediate II | US9273046, ...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIGENE, LTD. US Patent | Assay Description Compounds disclosed herein were tested against B-Raf (V600E) (PV3849, from Invitrogen) or C-Raf (Y340D/Y341D) (PV3805, from Invitrogen) in a time-res... | US Patent US10576087 (2020) BindingDB Entry DOI: 10.7270/Q2HM5BVQ | |||||||||||
More data for this Ligand-Target Pair |